TLR2 was overexpressed independent of IL-6 in patients with valvular atrial fibrillation

Journal of Biomedical Research

Volumn 25, Issue 3, 2011, Pages 178-184

  Wang, Jian ^a   Xue, Lei ^a   Cao, Hailong ^a   Cui, Fei ^a   Dai, Ting ^b   Chen, Yijiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Inflammation; Toll like receptor 2; Valvular heart disease

Indexed keywords

INTERLEUKIN 6; TOLL LIKE RECEPTOR 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART VALVE REPLACEMENT; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONTENT; RECEPTOR UPREGULATION; SINUS RHYTHM;

EID: 79959423006     PISSN: 16748301     EISSN: 16748301     Source Type: Journal    
DOI: 10.1016/S1674-8301(11)60023-7     Document Type: Article

References (34)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
2. You L, Wang P, Lv J, Cianflone K, Wang D, Zhao C The role of high-sensitivity C-reactive protein, inter-leukin-6 and cystatin C in ischemic stroke complicating atrial fibrillation. J Huazhong Univ Sci Technolog Med Sci 2010, 30:648-651.
3. Oh S, Kim KB, Ahn H, Cho HJ, Choi YS Remodeling of ion channel expression in patients with chronic atrial fibrillation and mitral valvular heart disease. Korean J Intern Med 2010, 25:377-385.
4. Ozaydin M Atrial fibrillation and inflammation. World J Cardiol 2010, 2:243-250.
5. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003, 108:3006-3010.
6. Gorshkova ES, Minushkina LO, Brovkin AN, Brazhnik VA, Nosikov W, Zateishchikov DA Genetic predisposition to development of atrial fibrillation in patients with hypertensive disease. Kardiologiia 2010, 50:19-24.
7. Chen LY, Shen WK Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm 2007, 4:S1-S6.
8. Anyukhovsky EP, Sosunov EA, Chandra P, Rosen TS, Boyden PA, Danilo P, et al. Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation. Cardiovas Res 2005, 66:353-363.
9. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006, 114:119-125.
10. Cheng TO Obesity as a risk factor for atrial fibrillation. Int J Cardiol 2007, 114:145.
11. Wang TJ, Parise H, Levy D, D'Agostino Sr RB, Wolf PA, Vasan RS, et al. Obesity and the risk of newonset atrial fibrillation. JAMA 2004, 292:2471-2477.
12. Eaker ED, Sullivan LM, Kelly-Hayes M, D'Agostino Sr SB, Benjamin EJ Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. Circulation 2004, 109:1267-1271.
13. Mukamal KJ, Tolstrup JS, Friberg J, Jensen G, Gronbaek M Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study. Circulation 2005, 112:1736-1742.
14. Boos CJ, Anderson RA, Lip GY Is atrial fibrillation an inflammatory disorder?. Eur Heart J 2006, 27:136-149.
15. Toutouzas K, Drakopoulou M, Dilaveris P, Vaina S, Gatzoulis K, Karabelas J, et al. Inflammation in lone atrial fibrillation: new insights by coronary sinus thermography. Int J Cardiol 2009, 134:345-350.
16. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997, 96:1180-1184.
17. Bruins P, te Velthuis H, Yazdanbakhsh AP, Janser PG, van Hardevelt FW, de Beaumont EM, et al. Activation of the complement system during and after cardiopul-monary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997, 96:3542-3548.
18. Pons J, Sauleda J, Regueiro V, Santos C, López M, Ferrer J, et al. Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease. Respir Res 2006, 7:64.
19. Chao W Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol 2009, 296:H1-12.
20. Candia L, Marquez J, Hernandez C, Zea AH, Espinoza LR Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity?. J Rheumatol 2007, 34:374-379.
21. Frolova L, Drastich P, Rossmann P, Klimesova K, Tlaskalova-Hogenova H Expression of Toll-like receptor 2(TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J Histochem Cytochem 2008, 56:267-274.
22. Bjørnvold M, Munthe-Kaas MC, Egeland T, Joner G, Dahl-Jørgensen K, Njølstad PR, et al. A TLR2 polymorphism is associated with type 1 diabetes and allergic asthma. Genes Immun 2009, 10:181-187.
23. Yang HZ, Cui B, Liu HZ, Chen ZR, Yan HM, Hua F, et al. Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune micro-environment. J Immunol 2009, 182:692-702.
24. Hausmann M, Kiessling S, Mestermann S, Webb G, Spöttl T, Andus T, et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 2002, 122:1987-2000.
25. Kim GT, Cho ML, Park YE, Yoo WH, Kim JH, Oh HJ, et al. Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis. Clin Rheumatol 2010, 29:273-279.
26. Huang QQ, Sobkoviak R, Jockheck-Clark AR, Shi B, Mandelin AM, Tak PP, et al. Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol 2009, 182:4965-4973.
27. Ichiki H, Orihara K, Hamasaki S, Ishida S, Oketani N, Iriki Y, et al. The role of infection in the development of non-valvular atrial fibrillation: Up-regulation of Toll-like receptor 2 expression levels on monocytes. J Cardiol 2009, 53:127-135.
28. Feng Y, Zhao H, Xu X, Buys ES, Raher MJ, Bopassa JC, et al. Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am J Physiol Heart Circ Physiol 2008, 295:H1311-H1318.
29. Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, Miyamoto T, et al. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 2003, 108:2905-2910.
30. Nakamura Y, Nakamura K, Fukushima-Kusano K, Ohta K, Matsubara H, Hamuro T, et al. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thromb Res 2003, 111:137-142.
31. Yared JP, Starr NJ, Torres FK, Bashour CA, Bourdakos G, Piedmonte M, et al. Effects of single dose, postinduction dexamethasone on recovery after cardiac surgery. Ann Thorac Surg 2000, 69:1420-1424.
32. Halonen J, Halonen P, Jarvinen O, Taskinen P, Auvinen T, Tarkka M, et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA 2007, 297:1562-1567.
33. Qu YC, Du YM, Wu SL, Chen QX, Wu HL, Zhou SF Activated nuclear factor-κB and increased tumor necrosis factor-α in atrial tissue of atrial fibrillation. Scand Cardiovasc J 2009, 43:292-297.
34. Kishimoto T, Akira S, Taga T Interleukin-6 and its receptor: A paradigm for cytokines. Science 1992, 258:593-597.